drugset / Trial / NCT01591759

A Pilot Trial of Citicoline in Individuals With Mild Traumatic Brain Injury (mTBI)

NCT01591759

Phase 2 Withdrawn Mclean Hospital
RandomizedParallel-groupSingle-blindTreatment

Summary

This investigation will explore the impact of 8 weeks of citicoline treatment on cognitive function, clinical state and substance use in 40 individuals with mild traumatic brain injury (mTBI).

Timeline

Start
2012-04
Primary completion
2014-04
Completion
2014-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Citicoline Other / unclassified 1000 mg